Vaccines From India, with Love?

Abstract

Since the beginning of the COVID-19 pandemic, India joined the club of select countries that announced vaccine development and roll out within a year. The Serum Institute of India based in Pune led the vaccine manufacturing in India in partnership with the main developer - University of Oxford. On the first day of 2021, the Drug Controller General of India approved the emergency use of the vaccine marketed as Covishield (AZD1222). Subsequently, the world’s largest vaccination drive began on 16 January 2021 with over half a million people vaccinated in the first three days.